Serum creatine kinase MM isoforms in hypertrophic cardiomyopathy. 1991

M Hamada, and T Ohtani, and M Sekiya, and Y Fujiwara, and T Sumimoto, and K Hiwada, and S Morita, and H Tsukada
2nd Department of Internal Medicine, Ehime University School of Medicine, Japan.

1. To determine whether a persistent release of creatine kinase from the myocardium occurs in patients with hypertrophic cardiomyopathy, the activities of serum creatine kinase MM isoforms were measured in 22 patients with hypertrophic cardiomyopathy and in 14 normal control subjects. 2. Serum creatine kinase MB activity was significantly higher in patients with hypertrophic cardiomyopathy (7.8 +/- 3.8 i.u./l) than in normal control subjects (0.4 +/- 0.8 i.u./l; P less than 0.01). 3. Serum MMa, MMb and MMc activities in patients with hypertrophic cardiomyopathy were 19.4 +/- 4.1%, 26.7 +/- 2.5% and 33.5 +/- 7.0% of the total creatine kinase MM activity, respectively. These values for each isoform were significantly different from those in normal control subjects (11.3 +/- 3.0%, 21.5 +/- 4.4% and 40.7 +/- 7.0%, respectively). The MMa/MMc activity ratio was significantly higher in patients with hypertrophic cardiomyopathy (0.61 +/- 0.25) than in normal control subjects (0.30 +/- 0.10; P less than 0.01). 4. Our results indicate that a small amount of the myocardial tissue isoform of creatine kinase MM (MMa) is constantly released in many patients with hypertrophic cardiomyopathy.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008297 Male Males
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D002312 Cardiomyopathy, Hypertrophic A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). Cardiomyopathy, Hypertrophic Obstructive,Cardiomyopathies, Hypertrophic,Cardiomyopathies, Hypertrophic Obstructive,Hypertrophic Cardiomyopathies,Hypertrophic Cardiomyopathy,Hypertrophic Obstructive Cardiomyopathies,Hypertrophic Obstructive Cardiomyopathy,Obstructive Cardiomyopathies, Hypertrophic,Obstructive Cardiomyopathy, Hypertrophic
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Hamada, and T Ohtani, and M Sekiya, and Y Fujiwara, and T Sumimoto, and K Hiwada, and S Morita, and H Tsukada
June 1988, Clinical chemistry,
M Hamada, and T Ohtani, and M Sekiya, and Y Fujiwara, and T Sumimoto, and K Hiwada, and S Morita, and H Tsukada
April 1997, Japanese circulation journal,
M Hamada, and T Ohtani, and M Sekiya, and Y Fujiwara, and T Sumimoto, and K Hiwada, and S Morita, and H Tsukada
June 1993, Chinese medical journal,
M Hamada, and T Ohtani, and M Sekiya, and Y Fujiwara, and T Sumimoto, and K Hiwada, and S Morita, and H Tsukada
June 1987, Cardiovascular research,
M Hamada, and T Ohtani, and M Sekiya, and Y Fujiwara, and T Sumimoto, and K Hiwada, and S Morita, and H Tsukada
August 1988, Clinical biochemistry,
M Hamada, and T Ohtani, and M Sekiya, and Y Fujiwara, and T Sumimoto, and K Hiwada, and S Morita, and H Tsukada
January 1993, American heart journal,
M Hamada, and T Ohtani, and M Sekiya, and Y Fujiwara, and T Sumimoto, and K Hiwada, and S Morita, and H Tsukada
September 1994, Clinica chimica acta; international journal of clinical chemistry,
M Hamada, and T Ohtani, and M Sekiya, and Y Fujiwara, and T Sumimoto, and K Hiwada, and S Morita, and H Tsukada
January 1998, Anales de medicina interna (Madrid, Spain : 1984),
M Hamada, and T Ohtani, and M Sekiya, and Y Fujiwara, and T Sumimoto, and K Hiwada, and S Morita, and H Tsukada
December 1990, Zhonghua xin xue guan bing za zhi,
M Hamada, and T Ohtani, and M Sekiya, and Y Fujiwara, and T Sumimoto, and K Hiwada, and S Morita, and H Tsukada
December 1985, The Journal of biological chemistry,
Copied contents to your clipboard!